Yunnan Metropolitan Real Estate Development (600239.SH) expects to incur a net loss of 35 million to 52.5 million yuan in the year 2024.
Yunnan Urban Investment Group (600239.SH) announced that the company expects the net profit attributable to the owners of the parent company in 2024 to...
Yunnan Metropolitan Real Estate Development (600239.SH) announced that the company is expected to incur a net loss attributable to the owners of the parent company of 35 million to 52.5 million yuan in 2024, a decrease of 53.85% to 30.77% compared to the same period last year.
The main reasons for the performance change are as follows: 1. The company disposed of the equity of two subsidiaries in a major asset restructuring in 2023, resulting in investment income; there were no external transfers of equity this period, leading to a decrease in investment income from the disposal of equity of 177 million yuan year-on-year. 2. In this period, based on the arbitration result and settlement agreement, overdue guarantee matters of the equity company Yunnan Chengjiang Eagle Land Resort Co., Ltd. were offset against estimated liabilities and confirmed debt restructuring income totaling 164 million yuan. 3. The company's commercial operation performance has improved slightly. 4. The company's equity companies are mainly engaged in real estate business, and the operating performance of the equity companies reported a loss during the reporting period, resulting in the company recognizing an investment loss of 98 million yuan. 5. The company made provisions for impairment of accounts receivable and inventory totaling approximately 59 million yuan.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


